The findings of the present study also suggested that monitoring of sleep duration in patients with T2D is warranted, particularly in those taking insulin, with early-onset diabetes, longer diabetes duration, poor glycemic control, and older age. The gene discussed is INS; the disease is diabetes mellitus.